MAXCYTE, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $33.0 | $38.6 | $41.3 | $44.3 | $33.9 |
| Operating income | -$51.9 | -$51.2 | -$48.3 | -$27.4 | -$18.2 |
| Net income | -$44.6 | -$41.1 | -$37.9 | -$23.6 | -$19.1 |
| Cash Flow Statement | |||||
| Free cash flow | -$36.2 | -$29.3 | -$25.4 | -$33.3 | -$14.5 |
Shares outstanding 103.2M · Free float 94.9%
Annual filing data through FY ended December 31, 2025; float as of September 27, 2026.